Company news: Haymarket Medical, Johnson & Johnson

Share this article:
Company news: Haymarket Medical, Johnson & Johnson
Company news: Haymarket Medical, Johnson & Johnson

Hitting the 1,000-download mark in less than a week, Haymarket Medical said its new myCME app has been an iTunes top 10 US medical app ever since. The May 10 launch was a universal app for iPhone/iPad and iPod users. An Android version will be released later this month. MM&M is a Haymarket title. 


Advanced prostate cancer drug Zytiga could help men who are in the earlier stages of the disease, reported the New York Times. The report was based on small, six-month clinical trial in which the Johnson & Johnson drug was added to standard therapy. The Times reported that the combination cleared or nearly eliminated tumors in about a third of the men whose cancer was still limited to the prostate gland. Full results will be reported at the American Society of Oncology's June conference in Chicago.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.